NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 174 filers reported holding NEVRO CORP in Q4 2016. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $506,000 | -99.9% | 13 | -99.8% | 0.00% | -100.0% |
Q3 2017 | $491,116,000 | +27.9% | 5,404 | +4.8% | 0.04% | +20.6% |
Q2 2017 | $383,910,000 | +61.5% | 5,158 | +103.3% | 0.03% | +54.5% |
Q1 2017 | $237,717,000 | +34.4% | 2,537 | +4.2% | 0.02% | 0.0% |
Q4 2016 | $176,927,000 | -26.5% | 2,435 | -25.4% | 0.02% | -26.7% |
Q2 2016 | $240,753,000 | – | 3,264 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |